Temat: "Epstein-Barr Virus Nuclear Antigens" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
Autorzy:: Viel KCMF; Molecular and Developmental Biology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Parameswaran S; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Donmez OA; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Forney CR; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Hass MR; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Yin C; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Jones SH; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Prosser HK; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Diouf AA; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Gittens OE; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Edsall LE; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Chen X; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Rowden H; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Dunn KA; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Guo R; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, 02111, USA.
VonHandorf A; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Leong MML; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Ernst K; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Kaufman KM; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Lawson LP; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Gewurz B; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Zhao B; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Kottyan LC; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA. .; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .
Weirauch MT; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA. .; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Mar 12; Vol. 25 (1), pp. 273. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Herpesvirus 4, Human*/genetics
Herpesvirus 4, Human*/metabolism
Epstein-Barr Virus Infections*/genetics
Epstein-Barr Virus Infections*/metabolism
Humans ; Genome, Human ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Viral Proteins/genetics ; Transcription Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
Autorzy:: Su C; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Lu F; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Soldan SS; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Lamontagne RJ; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Tang HY; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Napoletani G; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Farrell PJ; Imperial College, London, United Kingdom.
Tempera I; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Kossenkov AV; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Lieberman PM; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2021 Aug 05; Vol. 17 (8), pp. e1009834. Date of Electronic Publication: 2021 Aug 05 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Enhancer Elements, Genetic*
B-Lymphocytes/*virology
DNA-Binding Proteins/*genetics
Epstein-Barr Virus Infections/*virology
Epstein-Barr Virus Nuclear Antigens/*metabolism
Genes, MHC Class II/*physiology
Membrane Proteins/*genetics
Nuclear Proteins/*genetics
Trans-Activators/*genetics
Viral Proteins/*metabolism
B-Lymphocytes/metabolism ; DNA-Binding Proteins/metabolism ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Infections/metabolism ; Epstein-Barr Virus Nuclear Antigens/genetics ; Gene Expression Regulation ; Herpesvirus 4, Human/physiology ; Humans ; Membrane Proteins/metabolism ; Nuclear Proteins/metabolism ; Promoter Regions, Genetic ; Trans-Activators/metabolism ; Viral Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase.
Autorzy:: Dheekollu J; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Wiedmer A; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Soldan SS; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Castro-Muñoz LJ; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Chen C; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Tang HY; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Speicher DW; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Lieberman PM; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2023 Jun 01; Vol. 19 (6), pp. e1010478. Date of Electronic Publication: 2023 Jun 01 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase*/genetics
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase*/metabolism
Epstein-Barr Virus Infections*/genetics
Humans ; Herpesvirus 4, Human/genetics ; Lysine/genetics ; Proteomics ; DNA Replication ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Virus Replication ; Protein Stability ; Plasmids ; Replication Origin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events.
Autorzy:: Zhao B; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Mar 24; Vol. 15 (4). Date of Electronic Publication: 2023 Mar 24.
Typ publikacji:: Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:: Herpesvirus 4, Human*/physiology
Epstein-Barr Virus Infections*
Humans ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/metabolism ; B-Lymphocytes ; Viral Proteins/genetics ; Viral Proteins/metabolism ; Cell Line

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism.
Autorzy:: Lamontagne RJ; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Soldan SS; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Su C; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Wiedmer A; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Won KJ; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Lu F; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Goldman AR; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Wickramasinghe J; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Tang HY; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Speicher DW; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Showe L; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Kossenkov AV; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Lieberman PM; The Wistar Institute, Philadelphia, Pennsylvania, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2021 Jan 26; Vol. 17 (1), pp. e1009208. Date of Electronic Publication: 2021 Jan 26 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Cell Transformation, Viral*
B-Lymphocytes/*pathology
Chromatin/*genetics
Epstein-Barr Virus Infections/*pathology
Epstein-Barr Virus Nuclear Antigens/*metabolism
Nucleotides/*metabolism
Viral Proteins/*metabolism
B-Lymphocytes/metabolism ; B-Lymphocytes/virology ; Chromatin/metabolism ; Epigenesis, Genetic ; Epstein-Barr Virus Infections/metabolism ; Epstein-Barr Virus Infections/virology ; Epstein-Barr Virus Nuclear Antigens/genetics ; Herpesvirus 4, Human/physiology ; Host-Pathogen Interactions ; Humans ; Metabolome ; Transcriptome ; Viral Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Autorzy:: Begić V; Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.; Primary School 'Sesvetski Kraljevec', 10361 Sesvetski Kraljevec, Croatia.
Korać P; Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.
Gašparov S; Institute of Clinical Pathology and Cytology, Merkur University Hospital, 10000 Zagreb, Croatia.; Department of Pathology, Medical School Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
Rozman M; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Simicic P; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Zidovec-Lepej S; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 09; Vol. 23 (24). Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Hodgkin Disease*/pathology
Epstein-Barr Virus Infections*
Humans ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/metabolism ; Antigens, Viral/genetics ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Viral Matrix Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Autorzy:: Li C; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Romero-Masters JC; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Huebner S; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Ohashi M; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Hayes M; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Bristol JA; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Nelson SE; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Eichelberg MR; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Van Sciver N; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Ranheim EA; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Scott RS; Center for Molecular and Tumor Virology, LSU Health Sciences Center, Shreveport, Louisiana, United States of America.
Johannsen EC; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Kenney SC; Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2020 Jun 15; Vol. 16 (6), pp. e1008590. Date of Electronic Publication: 2020 Jun 15 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Epstein-Barr Virus Infections*/genetics
Epstein-Barr Virus Infections*/metabolism
Epstein-Barr Virus Infections*/pathology
Epstein-Barr Virus Infections*/virology
Gene Deletion*
Hodgkin Disease*/genetics
Hodgkin Disease*/metabolism
Hodgkin Disease*/pathology
Hodgkin Disease*/virology
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/metabolism
Lymphoma, Large B-Cell, Diffuse*/pathology
Lymphoma, Large B-Cell, Diffuse*/virology
Virus Latency*
Epstein-Barr Virus Nuclear Antigens/*genetics
Herpesvirus 4, Human/*physiology
Viral Proteins/*genetics
Animals ; Cell Line ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Herpesvirus 4, Human/pathogenicity ; Humans ; Mice ; Viral Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Effect of Epstein-Barr Virus Infection on Selected Immunological Parameters in Children with Type 1 Diabetes.
Autorzy:: Klatka M; Department of Pediatric Endocrinology and Diabetology, Medical University of Lublin, 20-093 Lublin, Poland.
Rysz I; Department of Pediatric Endocrinology and Diabetology, Medical University of Lublin, 20-093 Lublin, Poland.
Hymos A; Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Polak A; Department of Endocrinology, Medical University of Lublin, 20-093 Lublin, Poland.
Mertowska P; Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Mertowski S; Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Smolak K; Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Grywalska E; Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 25; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 25.
Typ publikacji:: Journal Article
MeSH Terms:: Epstein-Barr Virus Infections*
Diabetes Mellitus, Type 1*/complications
Humans ; Herpesvirus 4, Human ; Interleukin-17 ; Glycated Hemoglobin ; Antigens, Viral ; Epstein-Barr Virus Nuclear Antigens ; Fructosamine ; Interleukin-4 ; Antibodies, Viral ; Immunoglobulin G

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Autorzy:: Ponnusamy R; School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Khatri R; School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Correia PB; Section of Virology, Imperial College London, London, United Kingdom.
Wood CD; School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Mancini EJ; School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Farrell PJ; Section of Virology, Imperial College London, London, United Kingdom.
West MJ; School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2019 Jul 08; Vol. 15 (7), pp. e1007458. Date of Electronic Publication: 2019 Jul 08 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carrier Proteins/*metabolism
Epstein-Barr Virus Nuclear Antigens/*genetics
Epstein-Barr Virus Nuclear Antigens/*metabolism
Herpesvirus 4, Human/*genetics
Viral Proteins/*genetics
Viral Proteins/*metabolism
Amino Acid Sequence ; Amino Acid Substitution ; B-Lymphocytes/metabolism ; B-Lymphocytes/virology ; Binding Sites/genetics ; Carrier Proteins/chemistry ; Carrier Proteins/genetics ; Cell Cycle Proteins ; Cell Line ; Cell Transformation, Viral/genetics ; Cell Transformation, Viral/physiology ; Co-Repressor Proteins ; DNA-Binding Proteins ; Epstein-Barr Virus Nuclear Antigens/chemistry ; Genes, Viral ; Herpesvirus 4, Human/classification ; Herpesvirus 4, Human/pathogenicity ; Host Microbial Interactions/genetics ; Host Microbial Interactions/physiology ; Humans ; Models, Molecular ; Mutation ; Protein Interaction Domains and Motifs ; Protein Structure, Quaternary ; Trans-Activators/chemistry ; Trans-Activators/genetics ; Trans-Activators/metabolism ; Viral Proteins/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Combined assessment of Epstein-Barr virus viral capsid antigen and Epstein-Barr virus nuclear antigen-1 serology for post-transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients.
Autorzy:: Heldman MR; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Edlefsen KL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Pepper G; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Kapnadak SG; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
Rakita RM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Fisher CE; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Limaye AP; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Dec; Vol. 24 (6), pp. e13933. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:: Journal Article
MeSH Terms:: Epstein-Barr Virus Infections*/complications
Lymphoproliferative Disorders*/etiology
Organ Transplantation*/adverse effects
Adult ; Humans ; Epstein-Barr Virus Nuclear Antigens ; Herpesvirus 4, Human ; Retrospective Studies ; Cohort Studies ; Capsid ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA.
Autorzy:: Messick TE; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
Tolvinski L; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
Zartler ER; Quantum Tessera Consulting, LLC, Collegeville, PA 19426, USA.
Moberg A; GE Healthcare Bio-Sciences AB, Björkgatan 30, SE-751 84 Uppsala, Sweden.
Frostell Å; GE Healthcare Bio-Sciences AB, Björkgatan 30, SE-751 84 Uppsala, Sweden.
Smith GR; Fox Chase Chemical Diversity Center, Inc., 3805 Old Easton Road, Doylestown, PA 18902, USA.
Reitz AB; Fox Chase Chemical Diversity Center, Inc., 3805 Old Easton Road, Doylestown, PA 18902, USA.
Lieberman PM; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2020 Apr 10; Vol. 25 (7). Date of Electronic Publication: 2020 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Discovery*/methods
Antigens, Viral/*chemistry
DNA, Viral/*chemistry
DNA-Binding Proteins/*chemistry
Epstein-Barr Virus Nuclear Antigens/*chemistry
Nuclear Proteins/*chemistry
Antigens, Viral/metabolism ; DNA, Viral/metabolism ; DNA-Binding Proteins/metabolism ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Gammapapillomavirus ; Herpesvirus 4, Human ; Herpesvirus 8, Human/metabolism ; Humans ; Ligands ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Nuclear Proteins/metabolism ; Small Molecule Libraries ; Structure-Activity Relationship

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency.
Autorzy:: Wang Y; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Du S; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Zhu C; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Wang C; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Yu N; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Lin Z; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Gan J; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.; ShengYushou Center of Cell Biology and Immunology, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Guo Y; Department of Gynecology, Key laboratory of AIDS immunology of Ministry of Health, First Affiliated Hospital of China Medical University, Shengyang, P. R. China.
Huang X; Technical Center For Animal, Plant and Food Inspection and Quarantine of Shanghai Customs, Shanghai, P. R. China.
He Y; Technical Center For Animal, Plant and Food Inspection and Quarantine of Shanghai Customs, Shanghai, P. R. China.
Robertson E; Department of Otorhinolaryngology-Head and Neck surgery, Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Qu D; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Wei F; ShengYushou Center of Cell Biology and Immunology, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Cai Q; MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, Biosafety Level 3 Laboratory, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.; Expert Workstation, Baoji Central Hospital, Baoji, P. R. China.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2020 Mar 16; Vol. 16 (3), pp. e1008447. Date of Electronic Publication: 2020 Mar 16 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Epstein-Barr Virus Nuclear Antigens/*metabolism
Herpesvirus 4, Human/*physiology
Small Ubiquitin-Related Modifier Proteins/*metabolism
Ubiquitin-Protein Ligases/*metabolism
Virus Latency/*physiology
Amino Acid Motifs ; Cell Line ; Epstein-Barr Virus Nuclear Antigens/genetics ; Humans ; Small Ubiquitin-Related Modifier Proteins/genetics ; Tripartite Motif-Containing Protein 28/genetics ; Tripartite Motif-Containing Protein 28/metabolism ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Specific Peptidase 7/genetics ; Ubiquitin-Specific Peptidase 7/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
Autorzy:: Gain C; Department of Life Sciences, Presidency University, West Bengal, India.
Malik S; Department of Life Sciences, Presidency University, West Bengal, India.
Bhattacharjee S; Department of Life Sciences, Presidency University, West Bengal, India.
Ghosh A; Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata, India.
Robertson ES; Department of Otorhinolaryngology Head and Neck Surgery, and the Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Das BB; Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata, India.
Saha A; Department of Life Sciences, Presidency University, West Bengal, India.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2020 Feb 24; Vol. 16 (2), pp. e1008105. Date of Electronic Publication: 2020 Feb 24 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Autophagic Cell Death/*drug effects
Epstein-Barr Virus Nuclear Antigens/*metabolism
Herpesvirus 4, Human/*metabolism
Leupeptins/*pharmacology
Lysosomes/*metabolism
Oncogene Proteins/*metabolism
Proteasome Endopeptidase Complex/*metabolism
Proteasome Inhibitors/*pharmacology
Proteolysis/*drug effects
Animals ; Epstein-Barr Virus Nuclear Antigens/genetics ; HEK293 Cells ; Herpesvirus 4, Human/genetics ; Humans ; Lysosomes/genetics ; Mice ; Oncogene Proteins/genetics ; Proteasome Endopeptidase Complex/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Catastrophic antiphospholipid syndrome with Epstein-Barr virus-associated hemophagocytosis: A clinicopathological conference.
Autorzy:: Nawata A; Department of Pathology and Oncology, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Shirayama R; Department of Pediatrics, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Oshida K; Department of Pediatrics, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Sato T; Department of Pediatrics, 13780Kitakyushu City Yahata Hospital, Japan.
Ito T; Department of Pediatrics, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Shiba E; Department of Pathology and Oncology, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Kusuhara K; Department of Pediatrics, School of Medicine, 13137University of Occupational and Environmental Health, Japan.
Hisaoka M; Department of Pathology and Oncology, School of Medicine, 13137University of Occupational and Environmental Health, Japan.; Pokaż więcej
Źródło:: Lupus [Lupus] 2022 Oct; Vol. 31 (11), pp. 1385-1393. Date of Electronic Publication: 2022 Aug 07.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antiphospholipid Syndrome*/complications
Antiphospholipid Syndrome*/diagnosis
Epstein-Barr Virus Infections*/complications
Leukopenia*
Lupus Erythematosus, Systemic*/complications
Lymphohistiocytosis, Hemophagocytic*/diagnosis
Lymphohistiocytosis, Hemophagocytic*/etiology
Thrombocytopenia*/complications
Thrombosis*/etiology
Adolescent ; Adrenal Cortex Hormones ; Antibodies, Antiphospholipid ; Epstein-Barr Virus Nuclear Antigens ; Female ; Herpesvirus 4, Human ; Humans ; Immunoglobulin G ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Evolution of functional antibodies following acute Epstein-Barr virus infection.
Autorzy:: Karsten CB; University of Duisburg-Essen, University Hospital Essen, Institute for Translational HIV Research; Essen, Germany.
Bartsch YC; Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.
Shin SA; Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.
Slein MD; Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.
Heller HM; MIT; Cambridge, Massachusetts, United States of America.
Kolandaivelu K; MIT Institute for Medical Engineering & Science; Cambridge, Massachusetts, United States of America.
Middeldorp JM; VU University Medical Center; Amsterdam, Netherlands.
Alter G; Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.
Julg B; Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2022 Sep 06; Vol. 18 (9), pp. e1010738. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Epstein-Barr Virus Infections*
Antibodies, Viral ; Epstein-Barr Virus Nuclear Antigens ; Herpesvirus 4, Human ; Humans ; Immunoglobulin G ; Immunoglobulin M

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial　tissues of rheumatoid arthritis.
Autorzy:: Masuoka S; Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Kusunoki N; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.; Department of Inflammation and Pain Control Research, Toho University School of Medicine, Tokyo, Japan.
Takamatsu R; Department of Orthopedic Surgery, Toho University School of Medicine, Tokyo, Japan.
Takahashi H; Department of Orthopedic Surgery, Toho University School of Medicine, Tokyo, Japan.
Tsuchiya K; Department of Orthopedic Surgery, Toho University School of Medicine, Tokyo, Japan.
Kawai S; Department of Inflammation and Pain Control Research, Toho University School of Medicine, Tokyo, Japan.
Nanki T; Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Dec 11; Vol. 13 (12), pp. e0208957. Date of Electronic Publication: 2018 Dec 11 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Arthritis, Rheumatoid/*virology
Epstein-Barr Virus Infections/*genetics
Epstein-Barr Virus Nuclear Antigens/*immunology
Herpesvirus 4, Human/*genetics
Arthritis, Rheumatoid/genetics ; Arthritis, Rheumatoid/pathology ; Epitopes/genetics ; Epitopes/immunology ; Epstein-Barr Virus Infections/physiopathology ; Epstein-Barr Virus Infections/virology ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/isolation & purification ; Female ; HLA-DRB1 Chains/genetics ; HLA-DRB1 Chains/immunology ; Herpesvirus 4, Human/isolation & purification ; Herpesvirus 4, Human/pathogenicity ; Humans ; Male ; Osteoarthritis/genetics ; Osteoarthritis/physiopathology ; Osteoarthritis/virology ; Risk Factors ; Synovial Fluid/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.
Autorzy:: Wyżewski Z; Institute of Biological Sciences, Cardinal Stefan Wyszyński University, Dewajtis 5, 01-815 Warsaw, Poland.
Mielcarska MB; Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Nowoursynowska 166, 02-787 Warsaw, Poland.
Gregorczyk-Zboroch KP; Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Nowoursynowska 166, 02-787 Warsaw, Poland.
Myszka A; Institute of Biological Sciences, Cardinal Stefan Wyszyński University, Dewajtis 5, 01-815 Warsaw, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Jun 30; Vol. 23 (13). Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Epstein-Barr Virus Infections*/complications
Nasopharyngeal Neoplasms*
Apoptosis ; Epstein-Barr Virus Nuclear Antigens ; Herpesvirus 4, Human ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Autorzy:: Zhang S; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Pei Y; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Lang F; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Sun K; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Singh RK; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Lamplugh ZL; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Saha A; Department of Life Sciences, Presidency University, Kolkata, India.
Robertson ES; Department of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2019 Jan 07; Vol. 15 (1), pp. e1007514. Date of Electronic Publication: 2019 Jan 07 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Epstein-Barr Virus Infections/*metabolism
Epstein-Barr Virus Nuclear Antigens/*metabolism
Tumor Suppressor Proteins/*genetics
Antigens, Viral/genetics ; Apoptosis ; B-Lymphocytes/metabolism ; B-Lymphocytes/virology ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Transformation, Viral/genetics ; DNA Methylation/genetics ; Down-Regulation ; Epigenesis, Genetic/genetics ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Nuclear Antigens/genetics ; Gene Expression Regulation/genetics ; HEK293 Cells ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/metabolism ; Humans ; Lymphocyte Activation/genetics ; Promoter Regions, Genetic/genetics ; Tumor Suppressor Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: High-yield production of human Dicer by transfection of human HEK293-EBNA1 cells grown in suspension.
Autorzy:: Bouvette J; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.
Korkut DN; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.
Fouillen A; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.; Département de Stomatologie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, H3C 3J7, Canada.
Amellah S; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.
Nanci A; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.; Département de Stomatologie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, H3C 3J7, Canada.
Durocher Y; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, H4P 2R2, Canada.
Omichinski JG; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada.
Legault P; Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, H3C 3J7, QC, Canada. .; Pokaż więcej
Źródło:: BMC biotechnology [BMC Biotechnol] 2018 Dec 06; Vol. 18 (1), pp. 76. Date of Electronic Publication: 2018 Dec 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: DEAD-box RNA Helicases/*biosynthesis
Epstein-Barr Virus Nuclear Antigens/*genetics
HEK293 Cells/*metabolism
Ribonuclease III/*biosynthesis
DEAD-box RNA Helicases/analysis ; DEAD-box RNA Helicases/genetics ; Electrophoretic Mobility Shift Assay ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Gene Expression Regulation ; Humans ; Ribonuclease III/analysis ; Ribonuclease III/genetics ; Transfection

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Autorzy:: Zhou H; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, 430060, People's Republic of China.
Liu Y; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.
Wang C; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.; Department of Pathogen Biology, Weifang Medical University, Weifang, 261053, People's Republic of China.
Liu L; Department of corneal disease, Weifang Eye Hospital, Weifang, 261041, People's Republic of China.
Wang H; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.
Zhang Y; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.
Long C; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China.
Sun X; The State Key Laboratory of Virology, Department of Pathogen Biology, School of Basic Medical Sciences, Hubei Province Key Laboratory of Allergy and Immune-related Diseases, Wuhan University, 185 Eastlake Road, Wuhan, 430071, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 Aug 15; Vol. 37 (1), pp. 192. Date of Electronic Publication: 2018 Aug 15.
Typ publikacji:: Journal Article
MeSH Terms:: Diterpenes/*pharmacology
Epstein-Barr Virus Nuclear Antigens/*biosynthesis
Mitochondria/*drug effects
Nasopharyngeal Carcinoma/*drug therapy
Nasopharyngeal Neoplasms/*drug therapy
Phenanthrenes/*pharmacology
Animals ; Antineoplastic Agents, Alkylating/pharmacology ; Apoptosis/drug effects ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Epoxy Compounds/pharmacology ; Epstein-Barr Virus Nuclear Antigens/genetics ; Female ; HEK293 Cells ; HeLa Cells ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/pathology ; Nasopharyngeal Neoplasms/virology ; Proteasome Endopeptidase Complex/metabolism ; S Phase/drug effects ; Transfection

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Epstein-Barr Virus Nuclear Antigens"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język